Drugs and chemical maker IOL Chemicals & Pharmaceuticals today said it has got permission from the drug regulatory body of Canada to export ibuprofen - painkiller drug - to that country.
It has received DMF (Drug Master File) acknowledgement letter for ibuprofen from Health Canada, Therapeutic Products Directorate, Canada, IOL Chemicals & Pharmaceuticals said in a filing to the Bombay Stock Exchange.
The acknowledgement letter from the drug regulatory body of Canada would enable the pharma company to export ibuprofen to that country, it said.
However, the company did not reveal financial details of any contract to export the drug to Canada, nor did it specified about the quantity of the export.
The company manufactures bulk chemicals, such as acetic acid and speciality chemicals, including ethyl acetate and acetic anhydride under its chemical division.
Under the pharma division, the firm manufactures active pharmaceutical ingredient.
Shares of the company closed at Rs 57.50, down 1.96 per cent from the previous close on the BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app